Three Horizons Framework
for Manufacture of pesticides and other agrochemical products (ISIC 2021)
The agrochemical industry faces immense pressure to innovate, manage patent expiries, and adapt to rapidly shifting market and regulatory demands towards sustainability. The Three Horizons Framework directly addresses these core challenges by providing a structured approach to allocate resources...
Short, medium, and long-term strategic priorities
Protect the profitability and market share of existing conventional agrochemical products while proactively managing the 'patent cliff' (MD03, MD07) and optimizing operational efficiencies to sustain core revenues amidst increasing market obsolescence risks (MD01).
- Implement advanced product life cycle management for conventional active ingredients nearing patent expiry, focusing on new formulations, enhanced delivery systems, and regional re-registrations.
- Optimize global supply chain logistics and manufacturing processes for high-volume legacy products to reduce costs and improve margin retention in competitive markets (FR04).
- Launch targeted marketing and technical support programs to solidify customer loyalty for established brands against generic competition, highlighting efficacy and support services.
- Pursue selective regional M&A or licensing agreements to acquire complementary H1 product portfolios or bolster market presence in key agricultural regions.
Aggressively develop and commercialize next-generation sustainable solutions, such as bio-pesticides and precision agriculture tools, to pivot away from declining demand for conventional products (MD08) and address intensifying regulatory scrutiny (ER01).
- Accelerate R&D and regulatory approval for a diverse portfolio of bio-pesticides, bio-stimulants, and pheromone-based control products, prioritizing those with broad-spectrum efficacy.
- Develop and integrate precision agriculture technologies, including AI-driven application systems and digital scouting platforms, to optimize the use of both conventional and bio-agrochemicals.
- Form strategic partnerships and joint ventures with ag-tech startups, biotech firms, and academic institutions to co-develop novel delivery mechanisms and sustainable active ingredients (ER03, IN03).
- Expand offerings into Integrated Pest Management (IPM) advisory services, bundling products with data-driven recommendations and farmer support programs to create stickier customer relationships (MD05).
Invest in transformative, high-risk, long-term R&D (IN03) and disruptive business models that move beyond traditional chemical inputs, positioning the company as a leader in future-proof agricultural innovation, potentially leveraging biological improvement (IN01).
- Establish dedicated 'future farming' venture funds or internal incubators to invest in and pilot early-stage technologies like gene-editing for crop resilience, RNAi for pest control, or synthetic biology for nutrient creation.
- Explore and invest in novel, non-extractive nutrient management systems, such as advanced microbial soil inoculants or vertical farming solutions that decouple food production from traditional soil and climate dependencies.
- Conduct foundational research into autonomous farming systems and robotics for input application, aiming for ultra-precise, localized treatments with minimal environmental impact.
- Develop and test 'as-a-service' business models where crop protection and nutrition are provided as outcomes (e.g., yield guarantees) rather than through product sales, requiring deep data integration and risk-sharing with growers.
Strategic Overview
The Three Horizons Framework offers a structured approach for agrochemical manufacturers to manage their innovation portfolio amidst significant industry transformations. Given the dual pressures of maintaining profitability from established products (Horizon 1) and aggressively investing in next-generation sustainable solutions (Horizon 2 & 3), this framework provides clarity for R&D allocation, strategic partnerships, and long-term market positioning. It is particularly critical for navigating the 'patent cliff risks' (MD03, MD07) on conventional chemistries while simultaneously addressing the 'market obsolescence & substitution risk' (MD01) driven by increasing demand for biologicals and precision agriculture technologies.
Applying this framework allows firms to balance short-term revenue generation with mid-term growth opportunities and long-term disruptive potential. For an industry characterized by 'high R&D investment and risk' (MD01, IN05) and 'long time-to-market' (SC02), a disciplined approach to innovation pipeline management, from incremental improvements to radical breakthroughs like gene editing, is essential. This ensures a continuous flow of innovative products that meet evolving regulatory landscapes and consumer preferences, mitigating the 'risk of product obsolescence & stranded assets' (IN02) and securing future market relevance.
4 strategic insights for this industry
Proactive Patent Cliff Management through H1/H2 Alignment
The 'patent cliff' (MD03, MD07) is a significant threat, as conventional active ingredients lose exclusivity. The Three Horizons framework enables manufacturers to proactively manage this by ensuring a robust pipeline of H2 (next-generation) products, such as novel synthetics or early-stage biologicals, is ready to replace or augment H1 products nearing patent expiry, thus mitigating revenue loss and market share erosion.
Strategic Allocation for Sustainable Innovation
With 'intensifying regulatory scrutiny & bans' (ER01) and 'declining demand for conventional products' (MD08), the industry must pivot towards sustainable solutions. The framework guides strategic R&D budget allocation, ensuring sufficient investment in H2 (e.g., advanced biopesticides, integrated pest management solutions) and H3 (e.g., precision agriculture, gene-editing technologies like CRISPR) to secure long-term market relevance and address 'market obsolescence & substitution risk' (MD01).
Managing High-Risk, Long-Term R&D Investments
The agrochemical sector is characterized by 'high-risk, long-term R&D investment' (IN03) and 'exorbitant R&D and registration costs' (SC02). The 3H framework helps rationalize these investments by categorizing projects based on their time horizon and risk profile, allowing for a balanced portfolio that generates incremental improvements (H1), delivers future growth (H2), and explores transformative opportunities (H3) without over-committing to any single high-risk venture.
Building a Diversified Innovation Ecosystem
Given the 'high barriers to entry' (ER03) and 'high cost of continuous R&D and re-registration' (IN02), agrochemical firms cannot solely rely on internal R&D. The framework encourages building a diversified innovation ecosystem, leveraging partnerships, joint ventures, and M&A for H2 and H3 initiatives, particularly for emerging areas like microbial solutions or digital farming platforms, mitigating 'talent scarcity & retention' (ER07) and 'high financial risk & capital commitment' (IN05).
Prioritized actions for this industry
Establish a cross-functional Innovation Governance Board with explicit mandates for H1, H2, and H3 portfolios.
This ensures balanced resource allocation, clear strategic direction, and accountability across different innovation horizons, preventing H1 (sustaining) activities from monopolizing resources and ensuring H2/H3 (growth/future) projects receive adequate attention and funding, addressing 'High R&D Investment and Risk' (MD01).
Develop a formal 'Patent Expiry & Product Evolution' program linking H1 product lifecycle management with H2 pipeline development.
This program will proactively identify patent cliff risks and synchronize the development and market entry of next-generation or reformulated products to minimize revenue gaps and maintain market share, directly addressing 'Balancing Innovation with Patent Cliff Risks' (MD03) and 'Managing Patent Expiry Risks (Patent Cliff)' (MD07).
Allocate a dedicated percentage of the R&D budget (e.g., 10-15%) specifically for H3 'transformational' technologies and disruptive research.
This ring-fenced budget ensures exploration of truly disruptive opportunities like gene editing or novel biological mechanisms without being cannibalized by H1/H2 pressures. It fosters future growth avenues and mitigates 'Risk of Product Obsolescence & Stranded Assets' (IN02) and 'Navigating Divergent Technological Paths' (IN03).
Actively pursue strategic partnerships, M&A, and venture investments in H2/H3 areas, particularly with ag-tech startups and biotech firms.
Given the 'high barriers to entry' (ER03) and 'talent scarcity' (ER07) in emerging fields, external collaboration is critical. This accelerates access to new technologies (e.g., precision spraying, microbial inoculants) and market segments, reducing internal R&D burden and diversifying risk, especially for 'Maintaining Innovation Leadership' (ER07).
From quick wins to long-term transformation
- Conduct an immediate audit of the current R&D portfolio, categorizing all projects into H1, H2, or H3 based on their risk profile, market horizon, and strategic intent.
- Review existing patent portfolios and create a detailed timeline of patent expiries, identifying key products at risk and potential H1 strategies (e.g., reformulations, new uses).
- Formulate specific KPIs and funding rules for each horizon, ensuring that H2 and H3 projects are not prematurely judged by H1 financial metrics.
- Establish dedicated 'scouting' teams or external partnerships for H3, tasked with identifying emerging technologies and market shifts that could redefine the industry.
- Integrate the 3H framework into annual strategic planning and budget allocation processes.
- Develop a culture of continuous innovation and strategic foresight, where all employees understand their role in contributing to the different horizons.
- Build a robust 'incubation' or 'venture' arm for H3 projects, potentially with separate funding mechanisms and reporting structures to foster disruptive innovation outside core business constraints.
- Systematically track the conversion rates of projects from H1 to H2 to market, and H2 to H3 exploration, to optimize the innovation funnel.
- Underfunding or deprioritizing H2 and H3 in favor of immediate H1 returns, leading to future innovation gaps and market obsolescence.
- Applying H1 metrics (e.g., ROI, short-term profitability) to H2 or H3 projects, stifling early-stage innovation.
- Lack of clear governance and accountability for each horizon, leading to confusion and inefficient resource allocation.
- Becoming too rigid with horizon definitions, failing to recognize when an H2 project becomes H1 or an H3 opportunity matures into H2.
Measuring strategic progress
| Metric | Description | Target Benchmark |
|---|---|---|
| R&D Spend Allocation by Horizon | Percentage of total R&D budget allocated to H1 (sustaining), H2 (growth), and H3 (transformational) projects. | H1: 60-70%, H2: 20-30%, H3: 5-15% (Adjust based on strategic goals and market maturity). |
| New Product Revenue from H2/H3 | Percentage of total revenue generated from products launched in the last 5-10 years (H2) and from truly disruptive innovations (H3). | >30% from H2 products; >5% from H3 by year 10. |
| Patent Portfolio Health & Expiry Index | Number of key active patents, average remaining patent life, and projected revenue at risk due to patent expiries over the next 5-10 years. | Maintain average remaining patent life >5 years for core products; <10% revenue at risk from patent expiry in next 3 years. |
| Innovation Pipeline Velocity (H2/H3) | Average time from H2/H3 project inception to proof-of-concept, and from proof-of-concept to market launch or strategic partnership. | Reduce average H2/H3 time-to-market by 15% over 5 years. |
Other strategy analyses for Manufacture of pesticides and other agrochemical products
Also see: Three Horizons Framework Framework